Follow

As clinical guidelines shift, heart disease screening startup pulls in $43M Series B
Cleerly Coronary, a company that uses A.I powered imaging to analyze heart scans, announced a $43 million Series B funding this week. The funding comes at a moment when it seems that a new way of screening for heart disease is on its way
greenground.it/2021/06/23/as-c

Sign in to participate in the conversation
Mastodon Acerbo.me

a free community where sharing your ideas!